About Altasciences
5 Red Flags That Show Your CRO Isn’t Giving You the Attention You Deserve
Choose a CRO Who Understands Your Worth
Like any good relationship, going steady with a CRO should be about mutual commitment, transparency, and shared goals. But what if your CRO isn’t giving you the time and effort you deserve?
Here are five red flags that show your CRO isn’t making you a priority—and how Altasciences guarantees the support you deserve.
-
You always have to ask for attention.
Are you constantly chasing updates or feeling like an afterthought? It might be time to rethink your partnership. At Altasciences, we believe in the type of commitment where you never have to wonder where you stand or compete with late-phase deliverables. With a dedicated, cross-functional team by your side, you’ll always be a priority. No mixed signals—just clear, proactive updates.
-
They keep changing plans on you.
You’ve agreed on dates, but they’re always running late or delaying your studies. At Altasciences, size and spend don’t matter; whether you place one study or a complete program with us, we stay true to our commitment to you. And if timeline changes are a possibility, we will be able to anticipate them and present solutions before they happen. Our customized roadmaps and centralized scheduling system facilitate active timeline management, real-time responses, and proactive communication; you’ll know what activities are taking place in real time.
-
They’re making you repeat yourself.
If you’re constantly repeating information, they’re not putting in the effort to make your relationship easier. Think of partnering with Altasciences like a honeymoon period that never ends. With our proprietary database, Ask Albert, we capture and share your preferences, study requirements, drug information, and results across all departments and phases. That way, you’ll only have to Tell Us Once™.
-
They’re hard to reach.
If they take eons to respond to your calls or emails, they might be giving you the runaround. At Altasciences, you’ll never feel ignored. With a central point of contact, the same program managers will stick with you for your entire journey with us. And if you ever need extra insight, our executive team is just a call away. No games—just a partner who’s always within reach.
-
They’re all talk.
Promises are great, but if your CRO keeps making commitments they can’t keep, it’s time to re-evaluate.
Altasciences won’t ghost you for the next big crush; you are our partner, not a simple transaction. We are a CRO/CDMO that’s fully committed to you and your project, and we believe in transparency, responsiveness, and the importance of being dependable and honest. You deserve nothing less.
Discover how Altasciences could be the right CRO for you:
VIDEO:The True Meaning of Moving in Unison
Ingrid Holmes, VP of Global Clinical Operations, and Lynne Le Sauteur, VP of Laboratory Sciences, discuss how the synergy between our clinical and bioanalytical teams drives our integrated solution.
BLOG: 4 Essential Topics to Cover in Your First CRO Meeting
Chad Rathlef, Executive Director of Strategic Partnerships, and Lisa Sanford, VP of Business Development, outline how to navigate this pivotal moment and set yourself up for a long-lasting partnership.
VIDEO: QUICK CHAT with Chris Perkin—One Operational Structure
Altasciences' CEO, Chris Perkin, discusses how our internal structure differs from other CROs and CDMOs, and how this addresses a major challenge within the industry and accelerates timelines for clients.
Getting to the Heart of Science With Mélanie Constant
The Stories That Inspire
Meet Mélanie Constant, Manager of Microsoft Solutions. Her story is one of perseverance and is a reminder to us all of the important role of drug development. Through the most difficult times following her cancer diagnosis, Mélanie’s signature positivity was further solidified from seeing first-hand the impact of your work (and ours) on the world.
The Year in Review 2024
From Our Stocking to Your Inbox: Happy Holidays!
'Tis the season for a little extra joy, and we're thrilled to present "Questions From a Stocking: Holiday Edition!" in which Altascientists fully embrace the holiday spirit as they answer rapid-fire questions pulled from our new favorite stocking.
As we share these lighthearted moments, we're filled with deep gratitude for the ideas, discoveries, trials, and successes you've shared with us this year. Your partnership has been invaluable, and we're honored to support your efforts in bringing life-saving therapeutics to our global community.
From our stocking to your inbox, we wish you and your loved ones a very happy holidays.
Watch "Questions From A Stocking: Holiday Edition"
Getting to the Heart of Science with Yosuke Izumi
The Stories That Inspire
Meet Yosuke Izumi, one of our Directors of Business Development at Altasciences. From Japan to L.A., his career demonstrates his adaptability, an attribute that he uses in his personal life as well as in surfing. Each day presents new challenges—whether it’s helping you find your drug development solutions or mastering the ocean on his surfboard. Even with the best planning, unexpected things may happen, but Yosuke relies on his philosophy of always being solutions-oriented and knowing how to ride the waves.
4 Essential Topics to Cover in Your First CRO Meeting
Top Life Science Resources for Fall 2024
There’s a lot of life science content out there, so for your convenience, we’ve curated a selection of expert insights, tips, case studies, and scientific and regulatory information. Catch up on what you might have missed below!
Your Definitive Life Science Resource Guide is Back!
Top 10 Life Science Resources
We’ve curated a selection of recently published expert insights, tips, case studies, and scientific and regulatory information, just for you.
1. Webinar: Innovative Surgical Solutions in Safety Assessment Studies
Explore the latest advancements in surgical techniques for your toxicology and safety pharmacology studies. This webinar dives into innovative methods and techniques for new dose routes and procedures that help move your compounds one step closer to approval. Watch it now.
2. White Paper: Whole Genome Sequencing, Proteomics, and Function Characterization of the Sinclair Nanopig™
Discover how the Sinclair Nanopig™ is transforming nonclinical safety assessments. This comprehensive white paper details the genome sequencing and functional characterization of the Sinclair Nanopig™, offering key insights for pharmaceutical and biopharmaceutical safety evaluations. Read now.
3. Video: The True Meaning of Moving in Unison
See how collaboration and precision ensure seamless clinical trial implementation. Experts from Altasciences provide their insights on the importance of synergy between clinical and bioanalytical teams, and how you will benefit from our integrated CRO solution. Watch the video.
4. Blog: Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs
Explore how Altasciences evaluated the human abuse potential of mirogabalin, a CNS drug, by comparing it with diazepam and pregabalin in clinical trials. The study used a double-blind, crossover design with recreational drug users to evaluate subjective effects and likability. Read the case study.
5. The Altascientist: Issue 41—Immunomodulation Assessments for Clinical Trials: Sophisticated Bioanalytical Approaches to Support Complex Modalities
Uncover the complexities of immunomodulation in this issue of The Altascientist. This resource provides valuable insights into optimizing drug development while ensuring regulatory compliance and innovative solutions for immunotherapy. Read or listen now.
6. eBook: Key Considerations for Nonclinical AAV Gene Therapy Development
Explore the ins and outs of AAV gene therapy development. This eBook offers a detailed roadmap, from preclinical research through to bioanalytical testing and manufacturing, equipping you with the knowledge needed to smoothly navigate the complexities of gene therapy. Read now.
7. The Altascientist: Issue 40—Analytical Testing: Accurate and Complete Characterization of Your API
Discover how precise analytical testing ensures the proper absorption and therapeutic effect of your drug products. This issue of The Altascientist dives into methods for identifying and characterizing your API, common techniques to determine particle size distribution (PSD), and formulation approaches to maximize bioavailability. Read or listen here.
8. Infographic: Nanomilling—Enhancing Drug Solubility and Bioavailability
Learn how nanomilling, a cutting-edge manufacturing technique, can be used to tackle poor water solubility and bioavailability in drug development. This infographic provides an overview of how nanomilling works, offering a practical solution for improving the formulation of poorly soluble drugs. View the infographic.
9. Video: An Integrated CRO/CDMO
Discover how Altasciences breaks down organizational silos, streamlines project management, and provides effortless communication. In this video, leaders from across Altasciences come together to discuss how we safely accelerate your early-phase drug development journey using a seamless and integrated approach. Watch the video.
10. Fact Sheet: Clinical Trial Site Selection and Management
Learn how Altasciences can identify, select, and manage clinical trial sites to optimize patient enrollment, and ensure high data integrity throughout your study. Read the fact sheet.Recent Regulatory Updates:
- FDA Guidance Draft – Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
- FDA Final Guidance – Conducting Clinical Trials With Decentralized Elements
- FDA Final Guidance – Providing Regulatory Submissions in Electronic Format | Certain Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications Guidance for Industry
- FDA Final Guidance – ANDA Submissions | Amendments to Abbreviated New Drug Applications Under GDUFA
- EMA Guideline – Reflection Paper on Establishing Efficacy Based on Single-Arm Trials Submitted as Pivotal Evidence in a Marketing Authorization Application
Altasciences’ Chief Scientific Officer Named a PharmaVoice 100 Honoree
Greater Montréal, Québec, October 9, 2024 — Altasciences is proud to announce that Dr. Beatrice Setnik, PhD, has been honored as a PharmaVoice 100 winner. Dr. Setnik made the list of 100 honorees for her hands-on leadership and nearly 20 years of experience in clinical drug development, with a focus on abuse potential studies. In addition to her role as Chief Scientific Officer (CSO) at Altasciences, she serves as an adjunct professor at the University of Toronto and helps develop educational programs for children in her spare time.
PharmaVoice featured Dr. Setnik in an exclusive interview, highlighting her contributions to the life sciences field, and deeper insights into her visionary leadership and expertise. Selected from nominations by readers and colleagues, each honoree was evaluated by the PharmaVoice team and categorized into 10 distinct groups: Standout Leaders, Cancer Care Visionaries, Cardiometabolic All-Stars, Trailblazers, Biotech Pathfinders, Rare Disease Warriors, Tech and AI Wizards, Clinical Trial Pros, Patient Champions, and Cell and Gene Therapy Pioneers. Each winner represents the transformative impact of the pharmaceutical industry in their own unique way.
"Thank you very much to PharmaVoice for this honor, which would have been impossible without the support of my colleagues, the clients at Altasciences, and of course, my peers and collaborators over the years,” said Dr. Setnik. “To be included in a list of such incredible innovators and trailblazers is extremely humbling."
Dr. Setnik joined Altasciences as Chief Scientific Officer in 2019, working with her team to develop new clinical methods to safely study compounds in early-phase drug development, and adapting clinical methods to establish a safe, comfortable, stimulus-controlled environment for study participants. She has been previously recognized as a “Scientific Trailblazer” by Insights Care and was named one of the 30 Most Influential People in the Pharma Industry by The Medicine Maker in 2024.
“These honorees are inspirations. Their teams look to them for guidance, their patients for support, and their organizations for direction. Each winner represents progress toward a healthier future for everyone that is bolstered by science and technological advancements. We are excited to recognize their contributions through this annual list,” said Meagan Parrish, Lead Editor, PharmaVoice.
Since 2005, the PharmaVoice 100 has become one of the publication’s most anticipated features. From academia and nonprofits to Big Pharma, startups and tech companies, it is the only awards program in the industry that honors individuals from all sectors of life sciences. These honorees, from the clinic to the C-suite, are making meaningful contributions to their fields and striving to improve outcomes for patients around the world.
About Altasciences
Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster. To learn more about Altasciences, visit altasciences.com.
About PharmaVoice
PharmaVoice is a leading industry publication operated by Industry Dive. Our stories deliver the most important voices and ideas in the life sciences to industry leaders.
About Industry Dive
Industry Dive, an Informa business, is a leading business journalism company. Over 14 million decision-makers across 20+ competitive industries rely on our exclusive insight and analysis delivered through more than 30 publications.
Julie-Ann Cabana
Altasciences
+1 514 601-9763
jcabana@altasciences.com
Getting to the Heart of Science With Talita Conte, Scientific Project Manager
The Stories That Inspire
Meet Talita Conte, one of our dedicated scientific project managers. From São Paulo to Montréal, her journey is a testament to the power of passion and innovation in science. After making a breakthrough in myotonic dystrophy type 1 published in Nature Communications, she transitioned to project management at Altasciences, where she continues to drive fast-paced, impactful clinical trials.
